Therapeutic subgroup
N07 – ANDERE MITTEL FÜR DAS NERVENSYSTEM
- Anatomical main group N: NERVENSYSTEM
15Decisions
15Patient groups
Added benefit by patient group
- Considerable2
- Minor1
- Non-quantifiable4
- Not proven7
- Lesser benefit1
Subgroups
- N07B MITTEL ZUR BEHANDLUNG VON SUCHTERKRANKUNGEN 1 decision
- N07X ANDERE MITTEL FÜR DAS NERVENSYSTEM 14 decisions
Decisions, newest first
- 2026-01-22AmvuttraVutrisiranNot proven
- 2025-12-18SkyclarysOmaveloxolonNot proven
- 2025-10-16WainzuaEplontersenNot proven
- 2024-12-19QalsodyTofersenNon-quantifiable
- 2024-05-16OnpattroPatisiranLesser benefit
- 2023-09-21WakixPitolisantNon-quantifiable
- 2023-04-06AmvuttraVutrisiranMinor
- 2022-04-21OzawadePitolisantNot proven
- 2021-05-20VyndaqelTafamidisConsiderable
- 2021-05-20VyndaqelTafamidisNot proven
- 2019-03-22OnpattroPatisiranConsiderable
- 2019-03-22TegsediInotersenNon-quantifiable
- 2017-01-19WakixPitolisantNon-quantifiable
- 2015-02-19SelincroNalmefenNot proven
- 2012-08-02FampyraFampridinNot proven
Data status: 2026-10-29